SONOSCAPE(SZ:300633) Sou Hu Cai Jing·2025-12-11 13:44Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Kaili Medical (300633) as of December 11, 2025, with a closing price of 26.23 yuan, reflecting a decline of 2.16% [1] - The company reported a main revenue of 1.459 billion yuan for the first three quarters of 2025, an increase of 4.37% year-on-year, while the net profit attributable to shareholders decreased by 69.25% to 33.51 million yuan [2] - In Q3 2025, the company achieved a single-quarter main revenue of 495 million yuan, up 28.42% year-on-year, but reported a net loss of 13.52 million yuan, which is an increase of 78.05% in losses compared to the previous year [2] Group 2 - The company has a debt ratio of 24.22% and reported investment income of 2.08 million yuan, with financial expenses amounting to -38.30 million yuan, and a gross profit margin of 60.36% [2] - Over the past 90 days, 15 institutions have provided ratings for the stock, with 10 buy ratings and 5 hold ratings, and the average target price set by institutions is 4.128 billion yuan [2] - On December 11, 2025, the net inflow of main funds was 1.12 million yuan, accounting for 1.48% of the total transaction amount, while retail investors saw a net inflow of 1.57 million yuan, representing 2.06% of the total transaction amount [1]